# DermaVue Complete Classification Implementation

## Changes made

- Extended `partner_inference.py` to retain the actual seven-class CNN softmax outputs while preserving the original binary fusion path and thresholds.
- Extended `partner_adapter.py` to validate and return seven auxiliary class scores, their semantics, `scoreSource`, `diagnosisLevel`, subtype availability, and the explicit subtype-unavailable reason.
- Extended the `/api/cases/{case_id}/analyze` response contract through the adapter without changing the existing binary fields or release gate.
- Extended `model_adapter.py` `/api/model/info` metadata to distinguish final binary outputs from auxiliary seven-class CNN scores.
- Extended frontend analysis types and validation for score semantics and range checks.
- Reworked `frontend/components/results/results-view.tsx` to show the binary primary result, exact fused-score interpretation, auxiliary class-score breakdown, model/input details, warnings, and explicit subtype limitations.
- Preserved research-only disclaimer and production `503 model_unavailable` safety behavior when release serving is disabled.

## Tests actually executed

1. `py -3 -m unittest backend.test_partner_adapter backend.test_model_safety -v` — **7 tests passed**.
2. `frontend\pnpm exec tsc --noEmit` — initially found two nullable-score errors; fixed them, then **passed**.
3. `frontend\pnpm build` — **passed**; Next.js production build generated all routes.
4. Direct isolated real-model smoke using the authorized HAM10000 image — **passed**; all three CNNs and XGBoost loaded and the response contained seven validated auxiliary scores.
5. Live loopback research API smoke — **passed** with HTTP 200 and genuine model response; `researchMode=true`, binary result `BENIGN`, fused score `0.0135`, seven auxiliary scores, and disclaimer present.

## Safety and release state

- `evaluation_gate_passed` remains `false`.
- `serving_enabled` remains `false`.
- No model weights or thresholds were modified.
- The model still supports only a final binary decision. The seven-class scores are explicitly marked auxiliary and non-calibrated.
- No clinical validation or 90% accuracy claim is made.

## Remaining blockers

The final fused model would need a separately trained/evaluated multiclass head or classifier, with appropriate held-out genuine data and label mapping, before DermaVue could claim validated subtype detection. The current partner package does not provide that capability. Independent patient-level and duplicate-leakage review also remains a release requirement.
